Risk Classification Modeling to Combat Opioid Abuse
|
|
- Juliet Mosley
- 6 years ago
- Views:
Transcription
1 Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc Plaza America Drive Reston, VA
2 According to data from the Centers for Disease Control and Prevention (CDC), opioids contributed to over 40,000 deaths in 2016 and more than 1,000 people every day are treated for prescription-related opioid misuse. Practitioners that overexploit their authority to prescribe are provoking the unnerving rise in opioid-related patient safety issues, as well as increasing the risk of opioidrelated fraud and abuse. To help address this serious ongoing public health issue, organizations are beginning to leverage big data analytics to develop risk classification models that identify these bad agents, as well as the patients at the highest risk for substance abuse. Let s look at how silos of data across multiple organizations such as clinical care and pharmacy centers, public and private healthcare insurers, and state and federal agencies are being broken down and integrated to develop statistical models. Data Access, Data Collection and Data Usage It traditionally has been very difficult to access various types of claims data. For example, many oversight agencies do not have access to both clinical and pharmacy data. Public and private healthcare organizations often retain separate locations and access for their data, which creates a silo effect. Zoom out even further and you will find gaps in the Medicare and Medicaid system, the largest healthcare payer in the world when combined, yet these programs are administered separately at both the national and state level. Now, government healthcare payers, such as the Centers for Medicare and Medicaid Services (CMS) and the Department of Veterans Affairs (VA), are starting to play a big role by opening access to its claims data, as well as provider and eligibility data. With the Medicaid population being among the most vulnerable, accessing this type of data would allow the ability to see trends for providers that span states across various regions. When combined with other drug integrity programs, data analysts gain an even clearer and more thorough picture of prescription patterns for prescribers and dispensers. Additional efforts are being made to increase communication with state medical boards and other governing bodies in an effort to promote further cross-state data sharing. In fact, the President-appointed Opioid Commission recommended a slew of enhancements to the Prescription Drug Monitoring Program (PDMP) in a report released last fall. Law enforcement is becoming more involved in regional task forces and even broader Department of Justice efforts are being established in some of the highest-risk areas. With better mechanisms in place, the value of improving data sharing at the state level is critical in helping curb abuse of opioid distribution, particularly at the prescriber level. For example, dashboards could facilitate easier sharing and, as a result, produce more visibility and accountability
3 One of the hardest hit demographics is the veteran population. Within VA health systems, opiate prescriptions are readily accessible and distributed. Per the VA s own admission, the number of veterans reporting opioid addictions grew by 55 percent over a five-year period (from 2010 to 2015), and accounted for more than 68,000 veterans who suffer from opioid related disorders. The VA is an active participant in PDMPs. Using a statewide database, VA providers are able to access state information on controlled prescriptions dispensed to veterans outside the VA healthcare system. Available prescription data includes the type of medications prescribed, who issued the prescription, the amount or quantity prescribed and suggested dosage. As PDMP programs and information exchanges fully deploy nationwide, providers outside the VA will be able to access data on controlled prescriptions given to their patients from within the VA healthcare system. This bi-directional visibility will enable more informed insights into drug history and potential risks, resulting in better decision making that can reduce opioid misuse and abuse. Constructing Statistical Models Evaluating clinical and pharmacy claims analytics accelerates fraud, waste and abuse detection efforts. A statistical model can be constructed to identify patients at the highest risk for substance abuse and chemical overdoses based on predictive factors found in published, scientific literature on the topic, such as the following: Average daily dose Total supply of non-opioid drugs Overlapping prescriptions Number of prescribing and dispensing providers Past diagnoses, including those for mental illness or chronic pain Lack of appropriate drug testing Demographic information Special data packages can be constructed for each identified prescriber, listing the patients and claims associated with key actionable risk factors, including: average daily dosing in excess of the CDC-recommendation per day, patients assigned a substance abuse diagnosis by a different provider during the days supply of a prescription by the provider in question, and patients with a diagnosis of drug overdose from providers during the days supply of the prescription. A recipient risk score is created and rolled up to the provider level and, therein, flags providers with sizeable populations of risky patients. These providers are further scrutinized for other patterns of aberrant billing and potential fraud, waste and abuse in healthcare systems pdf 3
4 Results in Action Outcomes can be seen in provider investigations, collaboration with federal and state government, Medicare and Medicaid administrative actions, law enforcement investigations and medical board reviews. Using the model above, NCI leveraged Medicare and Medicaid data to conduct a study designed to identify high-risk prescribers of opioids. More than half a billion pharmacy claims and nearly 15 billion clinical claims were analyzed to determine the relationship between opioid prescription behavior and clinical outcomes. As claims are continually received, the model is refined and improved. From the original model, the results were significant. NCI referred 33 providers/groups for potential inappropriate prescribing practices for further investigation. All referrals were sent to the respective Medicaid Program Integrity units, with the majority sent to the state medical / license boards, CMS, Quality Improvement Organization (QIO), and, in some cases, the Medicare Drug Integrity Contractor (MEDIC) to potentially collaborate on mutually beneficial prescribers / pharmacies identified in the study. These referrals generated 27 Zone Program Integrity Contractor (ZPIC) investigations. The study identified millions of dollars at-risk in Medicare and Medicaid programs. Numerous bad agents have been identified and are referred for review to outside agencies and medical boards, and some states have organized task forces in response to addressing issues of high-risk opioid prescribers. The statistical model also has identified at-risk pharmacies, some of which have strong connections to the at-risk prescribers. Overcoming Challenges in Interoperability and Standards Providers at all levels of private and public healthcare organizations should continue to shore up their active participation in more frequent and collaborative data sharing. At the same time, industry has to help establish interoperable and integrated health information exchange systems and standards. Artificial intelligence (AI) could also become a bridge between federal and private payers as a way to facilitate and exchange data. As more models for risky providers or patient populations are developed and become established think of AI as the agent to scour the data for unforeseen trends and anomalies that could add and / or refine the model for providers and beneficiaries. As the practice of opioid prescribing continues to garner major scrutiny, opening up more pathways to access data is becoming very effective. The need to improve and facilitate opioid data exchange remains imperative as does the ability to capture, handle and access such a large amount of data across federal and state systems and queries. Virtualization and data management technologies are helping create pathways. Over 20 billion claims and millions of covered participants across every type 4
5 of healthcare benefit can be aggregated and analyzed to uncover risk in opioid fraud and abuse. Data can be retained in a highly virtualized and modern server environment and implementing predictive algorithms can help orient and store data in a fashion optimized for data analysis. The goal in combating the opioid crisis using this type of modeling envisions a future where providers can access data at the point of care, integrate it into their clinical workflows and EHR systems, and care for patients with effective pain management treatments that ultimately improve their longevity and wellness. Looking at predictive analytics and trends analysis of claims data can surface individual risk scores to intervene at the patient level, as well as aggregate at the prescriber and pharmacy levels, to flag practices contributing to the riskiest patient populations. About the Author Christopher Sterling helps to lead NCI s Agile & Analytics sector in combatting fraud, waste and abuse in Medicare and Medicaid healthcare systems. As chief statistician, he manages and conducts proactive data analysis in support of this goal. With a background in mathematics, specifically graph theory, Christopher has helped lay the groundwork for identifying complex networks of providers, and his interest in applying mathematical concepts in the fight against Medicare and Medicaid fraud has resulted in many successful recoveries for these programs. 5
6 Navigate, Collaborate, Innovate NCI is a leading provider of enterprise solutions and services to U.S. defense, intelligence, health and civilian government agencies. The company has the expertise and proven track record to solve its customers most important and complex mission challenges through technology and innovation. With core competencies in delivering cost-effective solutions and services in areas such as: Agile digital transformation Advanced analytics Artificial intelligence Cybersecurity and information assurance Engineering and logistics Fraud, waste and abuse detection Hyperconverged infrastructure Coupled with a refined focus on strategic partnerships, NCI is committed to bringing commercial innovation to missions of critical importance. Headquartered in Reston, Virginia, NCI has approximately 2,000 employees operating at more than 130 locations worldwide. For More Information, Contact: NCI contactnci@nciinc.com 6
Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationSeptember 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic
National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership
More informationCardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention
Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention The people of Cardinal Health care deeply about the devastation opioid abuse has caused American families and communities
More informationSuccessful Prevention Strategies to Address the Opioid Crises
Successful Prevention Strategies to Address the Opioid Crises Shannon Breitzman, MSW, Principal Denver Office Lindsey Kato, MPH, CHES, Consultant Denver Office 1 LEARNING OBJECTIVES + Find out how to effectively
More informationADDRESSING THE OPIOID CRISIS:
ADDRESSING THE OPIOID CRISIS: Preventing Abuse and Ensuring Patients Receive the Right Care in the Right Setting September 2018 EXECUTIVE SUMMARY Every day, about 115 Americans die from opioid abuse. 1
More informationFederal-State Response to the Opioid Crisis. Session 48 February 12, 2019
Federal-State Response to the Opioid Crisis Session 48 February 12, 2019 1 Conflict of Interest Thomas Novak, Medicaid Interoperability Lead, Office Of The National Coordinator / CMS Shereef Elnahal, MD,
More informationAlthough PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.
NASCSA Statement for the Record as presented by Barbara A Carter, President, NASCSA Submitted to: Department of Health and Human Services, Food and Drug Administration, Opioid Policy Steering Committee
More information20% A Holistic Approach Built on Evidence OF U.S. ADULTS EXPERIENCE MENTAL ILLNESS EACH YEAR
BEHAVIORAL HEALTH NEARLY 20% OF U.S. ADULTS EXPERIENCE MENTAL ILLNESS EACH YEAR Source: SAMHSA, 2018. Key substance use and mental health indicators in the United States: Results from the 2017 National
More informationHEALTH INFORMATION TECHNOLOGY: A POWERFUL TOOL IN ATTACKING THE OPIOID CRISIS PAUL L. UHRIG CHIEF ADMINISTRATIVE, LEGAL & PRIVACY OFFICER
HEALTH INFORMATION TECHNOLOGY: A POWERFUL TOOL IN ATTACKING THE OPIOID CRISIS PAUL L. UHRIG CHIEF ADMINISTRATIVE, LEGAL & PRIVACY OFFICER Copyright 2018 2017 by by Surescripts, LLC. All All rights reserved.
More information2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS)
2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS) Overview Value Partnerships, in conjunction with the Blue Cross Pharmacy team, has created the Electronic Prescribing of Controlled
More informationSTATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce
STATEMENT of the American Medical Association for the Record House Committee on Energy and Commerce RE: Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives October
More informationPDMP Tools to Identify Red Flag Situations
PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management
More informationPublic Health Federal Funding Request to Address the Opioid Epidemic
Public Health Federal Funding Request to Address the Opioid Epidemic On December 4, 2017, in response to the President s recent declaration of the opioid epidemic as a public health emergency and the final
More informationFHA CONNECT and Prescription Drug Monitoring
OS/ASA/OCIO/IO FHA CONNECT and Prescription Drug Monitoring Accessing patient prescription data by connecting to the Appriss PMP Gateway Jason Smith, Development Manager FHA CONNECT Robert Tagalicod, HHS
More informationUsing Predictive Analytics to Save Lives
March 2018 1 Using Predictive Analytics to Save Lives Presented by Sybil Klaus MD MPH, MITRE, and James Fackler MD, Johns Hopkins University School of Medicine Approved for Public Release; Distribution
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationHouse Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515
February 28, 2018 The Honorable Michael Burgess, M.D. The Honorable Gene Green Chairman Ranking Member Subcommittee on Health Subcommittee on Health House Committee on Energy and Commerce House Committee
More informationAssociation of State and Territorial Health Officials (ASTHO)
Association of State and Territorial Health Officials (ASTHO) Strategy Session on Prescription Drug Misuse and Abuse Prepared by: August 13-14, 2013 Table of Contents Introduction... 1 Setting Future Direction
More informationAppendix 3: Federal Government Agencies Involved in Immunization
Appendix 3: Federal Government Agencies Involved in Immunization Department of Health and Human Services (HHS) Secretary of Health and Human Services Directs all HHS activities. Office of the Assistant
More informationPrescription Opioid Overdose in Oregon: A public health perspective
Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,
More informationPennsylvania Prescription Drug Monitoring Program Trends,
DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly
More informationPrescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort
Prescription Monitoring Program Center for Excellence, Brandeis University April 10-12, 2012 Walt Disney World Swan Resort Accepted Learning Objectives: 1. Explain the current capabilities and contributions
More informationPDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health
PDMP Track: Linking and Mapping PDMP Data Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health Disclosure Statement Gillian Leichtling and Chris Baumgartner have disclosed no
More informationAddressing the Opioid Crisis An ACH Collaboration
Addressing the Opioid Crisis An ACH Collaboration The purpose of this document is to offer a set of strategies that can help hospitals, health systems, and independent/group practices and Accountable Communities
More informationImplementation: Public Hearing: Request for Comments (FDA-2017-N-6502)
March 16, 2018 via online submission: www.regulations.gov The Honorable Scott Gottlieb Commissioner Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Opioid Policy Steering
More informationSTATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.
STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. Arizona Corporate Counsel Presentation May 8, 2018 Agenda 1. Overview of the Opioid
More informationTri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent
More informationWednesday, June 21, Dear Chairmen and Ranking Members:
The Honorable Rodney Frelinghuysen Committee on Appropriations 2306 Rayburn House Office Building The Honorable Tom Cole Subcommittee on Labor, Health and Human Services, Education and Related Agencies
More informationSTATEMENT FOR THE RECORD. Submitted to the. Senate Committee on Health, Education, Labor, & Pensions
STATEMENT FOR THE RECORD Submitted to the Senate Committee on Health, Education, Labor, & Pensions The Opioid Crisis: The Role of Technology and Data in Preventing and Treating Addiction February 27, 2018
More informationChairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and
United States House of Representatives Committee on Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade Hearing on Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield
More informationThe Role of Prescription Drug Monitoring Programs in Managing Opioids:
The Role of Prescription Drug Monitoring Programs in Managing Opioids: A vital component to addressing Opioid Addiction in value-based care delivery Michael Sprintz DO, FASAM CEO, Cellarian Health Founder,
More informationVanila M Singh, MD MACM Chief Medical Officer Office of the Assistant Secretary for Health U.S. Department of Health and Human Services
Vanila M Singh, MD MACM Chief Medical Officer Office of the Assistant Secretary for Health U.S. Department of Health and Human Services 1 Summit Objectives Engage subject matter experts and key federal,
More informationPrescription Drug Abuse National Perspective
Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs
More informationProject Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data
Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Presented to Bureau of Justice Assistance Harold Rogers Prescription
More informationSafe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review
Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review 1 Initiative #1: Aiming for Equity in Sexual Violence Prevention - Mapping Risks, Policies, Outcomes and Resources Statement
More informationSeptember 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
More informationHarold Rogers Update Melissa McPheeters, PhD, MPH
Harold Rogers Update 2017 Melissa McPheeters, PhD, MPH We Need a New Normal Full collaboration among diverse departments Appropriate integration of data from disparate data sources Business intelligence
More informationAppearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse
Opening Statement Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse Dr. Chris Simpson, President-elect
More informationMELISSA STAHL SENIOR RESEARCH MANAGER THE HEALTH MANAGEMENT ACADEMY
CASE STUDY MANAGING THE OPIOID EPIDEMIC: FAIRVIEW HEALTH SERVICES The Academy The Health Management Academy MELISSA STAHL SENIOR RESEARCH MANAGER THE HEALTH MANAGEMENT ACADEMY INTRODUCTION THE OPIOID EPIDEMIC
More informationPennsylvania s Opioid Crisis: Data and Strategies to Combat It
Data and Strategies to Combat It May 8, 2018 Phillip M. Burrell Director, Research & Data Analytics The Hospital + Healthsystem Association of Pennsylvania Agenda The PA opioid crisis Trends Responses
More informationFIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH
FIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH The Public Health Crisis of This Generation & Delaware s Plan for the Future Lt. Governor Bethany Hall-Long, Ph.D, RNC, FAAN INTRODUCTION BEHAVIORAL HEALTH
More informationCONFRONTING THE OPIOID EPIDEMIC. e-book: Introducing OptumRx Opioid Risk Management
CONFRONTING THE OPIOID EPIDEMIC 2 0 1 8 OPIOID ABUSE IS A CRISIS IN THE U.S. OptumRx Opioid Risk Management attacks this complex, deeply embedded problem with a comprehensive approach featuring five interrelated
More informationAmerican Academy of Pain Medicine American Pain Society American Society of Anesthesiologists
PAIN CARE COALITION A National Coalition for Responsible Pain Care American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists August 29, 2017 The Honorable Chris Christie,
More informationThe Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose
The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose 1 Learning Objectives Identify pain treatment related regulatory agencies Discuss the changing role of regulatory
More informationThe Opioid Crisis among the Privately Insured
The Opioid Crisis among the Privately Insured The Opioid Abuse Epidemic as Documented in Private Claims Data A FAIR Health White Paper, July 2016 Copyright 2016, FAIR Health, Inc. Summary The United States
More informationOverview of ASHP Opioid Efforts
Overview of ASHP Opioid Efforts Deborah A Pasko, Pharm.D, MHA Director, Medication Safety & Quality Nicholas Gentile Director, State Grassroots Advocacy and Political Action Presenter My educational background
More informationBREAKING THE CYCLE T H E O P I O I D E P I D E M I C I N A M E R I C A
BREAKING THE CYCLE T H E O P I O I D E P I D E M I C I N A M E R I C A OVERVIEW Across the United States, about 90 people die per day due to opioid overdoses, which equates to every three in five overdose
More informationToday s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care
Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care 203 - Monday, April 16, 2018 Today s Presenters Ben Purser Former F.B.I. Special Agent Donna Thiel ProviderTrust Chief
More informationNational Strategies for Local Solutions
National Strategies for Local Solutions LCDR Michael R. Muni, MPA, MPH National Heroin Task Force Education and Community Awareness Committee s Staff Lead Substance Abuse Mental Health Services Administration
More informationCollaborative for Effective Prescription Opioid Policies
The Honorable Richard Shelby Committee on Appropriations 304 Senate Office Building The Honorable Roy Blunt Subcommittee on Labor, Health and Human Services, Education and Related Agencies 260 Russell
More informationJuly 6, Dear Governor Christie:
July 6, 2017 The Honorable Chris Christie Chair President s Commission on Combating Drug Addiction and the Opioid Crisis White House Office of National Drug Control Policy 750 17th Street, N.W. Washington,
More informationWA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24
WA PMP Access by Public Payers PDMP North Regional Meeting St. Louis, MO April 23-24 Public Insurer Access PDMP Statute: Allows PDMP data to be provided to Medicaid and Workers Compensation Primary Goal:
More informationAddressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust
Addressing Prescription Drug Abuse Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Outline 1. Prescription Drug Monitoring Programs 2. Federal policy landscape including
More informationManaged Care Pushes for Safer Opioid Oversight
Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging
More informationMANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling
MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin
More informationExecutive Summary Background: The Costs and Damage Caused by Drug Diversion
Are We Doing Enough? Executive Summary In 2017, Porter Research conducted a survey about the theft of narcotics by US healthcare workers. Onehundred fifty health care professionals, representing over one-hundred
More informationManaging Opioid Overutilization Challenges
One Source. Lower Cost. Better Care. Managing Opioid Overutilization Challenges A LOOK AT REDUCING OPIOID OVERUTILIZATION BY 36 PERCENT Copyright 2017 MedImpact Healthcare Systems, Inc. All rights reserved.
More informationAssessing Opioid Misuse and Overdose Using Prescription Drug Monitoring Programs (PDMP) and Other Data Sources
Assessing Opioid Misuse and Overdose Using Prescription Drug Monitoring Programs (PDMP) and Other Data Sources NPN Conference Anaheim, CA September 12, 2017 Presentations Overview of SAMHSA s Prevention
More informationState Action to Prevent and
State Action to Prevent and Treat Prescription Drug Abuse Paul Jarris, MD, MBA Executive Director Association of State and Territorial Health Officials Hearing from Each Other: State Reports NGA Policy
More informationCombating Opiate Addiction
Combating Opiate Addiction Patrick E Keefe Chief of Police July 2015 Statement of the Problem The recent heroin epidemic has spared no community or law enforcement agency. The wide availability of heroin
More informationNew Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS
New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February
More informationDo you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President
Do you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President AGENDA 01 03 05 07 By The Numbers PDMPs in CARA Action Since Enactment Questions? 02 CARA Basics 04 What
More informationOPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION
OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION The Department of Human Services (DHS) is implementing 50 opioid use disorder (OUD) Health Homes or Centers of Excellence (COE)
More informationPrescription Drug Monitoring Programs and Other State-Level Strategies
Prescription Drug Monitoring Programs and Other State-Level Strategies Interventions to Reduce Opioid-Related Harms: Misuse, Abuse, Addiction, and Overdose Tamara M. Haegerich, PhD Acting Associate Director
More informationComplex just became comfortable.
Complex just became comfortable. DENTRIX ENTERPRISE Work Well With Others To serve your community, your clinic must work well with others other providers, other clinics, other organizations. To be effective,
More informationData-Driven Prevention Initiative
Data-Driven Prevention Initiative Arturo Brito, MD,MPH Deputy Commissioner New Jersey Department of Health Pain, Pain Management & Opioid Epidemic Symposium Princeton, New Jersey December 2, 2016 Reducing
More informationTelligen Quality Innovation Network Quality Improvement Organization
Telligen Quality Innovation Network Quality Improvement Organization PQA Patient Safety Measures for Inappropriate Prescription Opioid Use August 29, 2017 Optimizing Patients' Health by Improving the Quality
More informationThe STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018
The STOP Measure Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 AHIP s Safe, Transparent Opioid Prescribing (STOP) Initiative Methodology
More informationOpioid Response Package Awaits President s Signature Trinity Tomsic
Issue Brief 18-38, October 19, 2018 Opioid Response Package Awaits President s Signature Trinity Tomsic 202-624-8577 ttomsic@ffis.org Summary Congress passed the SUPPORT for Patients and Communities Act
More informationSubstance Use Disorders: A Path Forward for Michigan
Substance Use Disorders: A Path Forward for Michigan DEBRA A. PINALS, M.D. MEDICAL DIRECTOR BEHAVIORAL HEALTH AND FORENSIC PROGRAMS MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES Tackling the opiate
More informationOregon Opioid Prescribing Guidelines
Oregon Opioid Prescribing Guidelines Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Jim Rickards, MD, MBA Chief Medical Officer Oregon Health Authority Personal
More informationBlue Cross of Idaho Addresses State s Opioid Issue
Blue Cross of Idaho Addresses State s Opioid Issue BY THE NUMBERS - Opioid Management page 3 THE PROBLEM - How Preventing Pain Hurt Us page 4 THE SOLUTIONS - Idaho State Board Of Pharmacy Prescription
More informationEXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS
EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationMeth and Opioid Abuse Prevention Efforts
Meth and Opioid Abuse Prevention Efforts Prescription Drugs/Opioids in South Dakota Departments of Health and Social Services Drug Abuse in South Dakota South Dakota ranked 2 nd lowest in the nation for
More informationOpioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016
Opioids: What You Should Know About Opioid Prescribing Denis G. Patterson, DO Nevada State Medical Association October 19, 2016 Contact Information Denis G. Patterson, DO Nevada Advanced Pain Specialists
More informationPresentation Overview
Navigating the Changing Regulatory Enforcement Landscape Relating to Opioids Anna M. Grizzle Tizgel K.S. High Jerry Williamson, M.D. Presentation Overview Recent Enforcement Actions Physician s Perspective
More informationQUALITY IMPROVEMENT TOOLS
QUALITY IMPROVEMENT TOOLS QUALITY IMPROVEMENT TOOLS The goal of this section is to build the capacity of quality improvement staff to implement proven strategies and techniques within their health care
More informationProactive Analysis of Specialized Databases
Proactive Analysis of Specialized Databases Using Visual Analytics to Expose Patterns and Trends Presented by: Ronald Stanko, Chief Deputy Attorney General Robert Dintino, Senior Supervisory Special Agent
More informationEHR Developer Code of Conduct Frequently Asked Questions
EHR Developer Code of Conduct Frequently Asked Questions General What is the purpose of the EHR Developer Code of Conduct? EHR Association (the Association) members have a long tradition of working with
More informationCDC s Approach to Addressing the Opioid Overdose Epidemic
CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths
More informationADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans
ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans DEPARTMENT: Medicare Compliance POLICY TITLE: RELATED DEPARTMENTS: All POLICY #: 706 C VERSION #: 4 REVISION DATE: Identifying
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
More informationWashington State PMP Data Mapping Project
Washington State PMP Data Mapping Project 2014 Category 3 Grant Harold Rogers Category 3 Grantee Meeting February 25, 2015 Washington State BACKGROUND: OPIOID ISSUES AND PLANNING 2 WA Unintentional Opioid
More informationThomas McLellan Velma V. Taormina William Gross Barbara Hallisey
2 Thomas McLellan, PhD, Founder and Chairman of the Board, Treatment Research Institute, former Deputy Director of the Office of National Drug Control Policy Velma V. Taormina, MD MSE FACOG, Medical Director,
More informationMedicaid and the Opioid Crisis
Medicaid and the Opioid Crisis Erica Floyd Thomas Bureau Chief of Medicaid Policy Agency for Health Care Administration Presented to: Medical Care Advisory Committee March 20, 2018 1 Florida Medicaid Covers
More informationPediatric Restorative Benefits: Potential for Fraud & Abuse
1 Pediatric Restorative Benefits: Potential for Fraud & Abuse Part 2 The Medicaid-Commercial Spectrum, Media Reports of Abuse, U.S. Senate Study, Quest for the Facts and a Plan of Action Craig Kasten Wednesday
More informationBattling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic
Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic Speakers: Margarita Pereyda, M.D., Principal, Moderator: Carl Mercurio, Information Services September 29, 2015 HealthManagement.com
More informationThe Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018
The Opioid Epidemic and How It is Impacting the Workplace July 24, 2018 In 2016 CDC reports a 300% increase in opioid prescription sales since 1999 without an overall change in reported pain National Safety
More informationSurveillance and Prevention of NCDs : Applying LHS Principles to Kidney Disease
Surveillance and Prevention of NCDs : Applying LHS Principles to Kidney Disease Rajiv Saran, MBBS, MD, MRCP, MS Florence E. Bingham Professor of Nephrology Professor of Medicine and Epidemiology Director,
More informationSUBHEAD GOES HERE. Addressing Tennessee s Opioid Crisis. Natalie A. Tate, PharmD Vice President, Pharmacy
SUBHEAD GOES HERE Addressing Tennessee s Opioid Crisis Natalie A. Tate, PharmD Vice President, Pharmacy Our opioids story Our approach Our response to neonatal abstinence syndrome Facts and faces of opioid
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:
Statement Of The National Association of Chain Drug Stores For U.S. Senate Finance Committee Hearing on: 10:30 a.m. 215 Dirksen Senate Office Building National Association of Chain Drug Stores (NACDS)
More informationSuicide Prevention Strategic Plan
Suicide Prevention Strategic Plan 2019 For more information visit dphhs.mt.gov/suicideprevention 2 Vision Zero suicide in the Big Sky State Mission Our Reduce suicide in Montana through a comprehensive,
More informationModule 6: Substance Use
Module 6: Substance Use Part 1: Overview of Substance Abuse I am Martha Romney and I am presenting on substance abuse. This module focuses on the healthy people 2020 objective to reduce substance abuse
More informationImplementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse
Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health
More informationDefense Health Agency PROCEDURAL INSTRUCTION
Defense Health Agency PROCEDURAL INSTRUCTION NUMBER 6025.04 DHA/Healthcare Operations SUBJECT: Pain Management and Opioid Safety in the Military Health System (MHS) References: See Enclosure 1. 1. BACKGROUND.
More informationA COMPREHENSIVE APPROACH TO MANAGING DIABETES
A COMPREHENSIVE APPROACH TO MANAGING DIABETES Programs and services to help individuals avoid costly complications and improve outcomes 2 0 1 8 ENTER Supporting each member with targeted guidance and services.
More informationVA Walgreens Collaboration
VA Walgreens Collaboration Harry Leider, Chief Medical Officer Jim Wood, Vice President Federal December 15, 2015 Overview Walgreens Background VA / Walgreens Relationship VA Immunization Program IT Architecture
More informationAbout the Division of Public Health The Role of the Division of Public Health in Influencing Health
About the Division of Public Health A division of the North Carolina Department of Health and Human Services (DHHS), the Division of Public Health (DPH) works to promote and contribute to the highest possible
More information